Consumption of oxycodone prevents oxytocin from attenuating alcohol intake in rats

Alcohol and opioid polysubstance use (PSU) is common and often accompanied by higher trait anxiety. Oxytocin decreases anxiety, alcohol- and opioid-seeking and -taking but has not been assessed in the context of PSU. Here we developed a rat model of sequential oxycodone and alcohol PSU to examine th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alcohol (Fayetteville, N.Y.) N.Y.), 2024-10
Hauptverfasser: Wilkinson, C.S., Modrak, C.G., Thompson, T.D., Conrad, R.C., Leon, I., Knackstedt, L.A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Alcohol (Fayetteville, N.Y.)
container_volume
creator Wilkinson, C.S.
Modrak, C.G.
Thompson, T.D.
Conrad, R.C.
Leon, I.
Knackstedt, L.A.
description Alcohol and opioid polysubstance use (PSU) is common and often accompanied by higher trait anxiety. Oxytocin decreases anxiety, alcohol- and opioid-seeking and -taking but has not been assessed in the context of PSU. Here we developed a rat model of sequential oxycodone and alcohol PSU to examine the relationship between anxiety, alcohol and oxycodone intake, and the efficacy of systemic oxytocin to attenuate alcohol intake. Male and female Sprague-Dawley rats were assessed for baseline anxiety-like behavior using acoustic startle and the elevated plus maze (EPM). Rats were then given 2-bottle choice access to oxycodone and/or water for 6-hr/day for 7 days, followed by 2-bottle choice access to alcohol (20% v/v) and/or water for five 24-hr sessions across 10 days. Next, monosubstance (oxycodone- or alcohol-alone) rats continued to have access to only one substance/day while PSU rats had access to oxycodone and water for 3-hr, followed by alcohol and water for 6-hr. After 12 days, rats were tested in the EPM 20 hours after alcohol access to examine withdrawal-related anxiety. Next, oxytocin (0, 0.3 or 1.0 mg/kg IP) was administered following the oxycodone/water session, 30 minutes prior to alcohol access. Rats received intragastric oxycodone (2 mg/kg) or water followed by intragastric alcohol (2 g/kg) and blood was collected to determine blood alcohol levels. Elevated baseline anxiety-like behavior was accompanied by reduced alcohol intake. Consumption of oxycodone did not alter alcohol intake but resulted in less anxiety-like behavior during withdrawal and prevented oxytocin from attenuating alcohol intake. Oxytocin (1 mg/kg) reduced alcohol intake in the alcohol-only condition, an effect that persisted for days after a single oxytocin administration. Rats that received oxycodone prior to non-contingent alcohol displayed higher blood alcohol levels than those that did not. These results support the necessity for the testing of medications for substance use in rodent models of PSU. •Sequential oxycodone-alcohol intake does not influence intake of either drug.•Systemic oxytocin reduces alcohol intake in rats.•A history of oxycodone consumption prevents oxytocin from reducing alcohol intake.•Sequential consumption of oxycodone and alcohol results in less anxiety-like behavior.
doi_str_mv 10.1016/j.alcohol.2024.10.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3120596331</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0741832924001289</els_id><sourcerecordid>3120596331</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1581-f06e1357cee3af7fdaa71545bb673697a9c14db6cf801df08959500b0faa6e893</originalsourceid><addsrcrecordid>eNqFUMFqGzEUFKEhdtx-Qssee1n3abVarU6lmKQNBAIhOQut9imRuyu5ktbEf581dnvtaWCYefNmCPlMYU2BNt-2az2Y8BqGdQVVPXNrgOqCLGkrWNm0FftAliBqWraskgtyndIWAIQQ8oosmKxr0XK6JI-b4NM07rILvgi2CG8HE_rgsdhF3KPP6UjlYJwvbAxjoXNGP-ns_Etx_qBwPuvfOEMRdU4fyaXVQ8JPZ1yR59ubp82v8v7h593mx31pKG9paaFByrgwiExbYXutBeU177pGsEYKLQ2t-64xtgXaW2gllxygA6t1g61kK_L1dHcXw58JU1ajSwaHQXsMU1KMVsBlwxidpfwkNTGkFNGqXXSjjgdFQR3nVFt1LqOOcx7pec7Z9-UcMXUj9v9cf_ebBd9PApyL7h1GlYxDb7B3EU1WfXD_iXgH_WmKVg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3120596331</pqid></control><display><type>article</type><title>Consumption of oxycodone prevents oxytocin from attenuating alcohol intake in rats</title><source>Access via ScienceDirect (Elsevier)</source><creator>Wilkinson, C.S. ; Modrak, C.G. ; Thompson, T.D. ; Conrad, R.C. ; Leon, I. ; Knackstedt, L.A.</creator><creatorcontrib>Wilkinson, C.S. ; Modrak, C.G. ; Thompson, T.D. ; Conrad, R.C. ; Leon, I. ; Knackstedt, L.A.</creatorcontrib><description>Alcohol and opioid polysubstance use (PSU) is common and often accompanied by higher trait anxiety. Oxytocin decreases anxiety, alcohol- and opioid-seeking and -taking but has not been assessed in the context of PSU. Here we developed a rat model of sequential oxycodone and alcohol PSU to examine the relationship between anxiety, alcohol and oxycodone intake, and the efficacy of systemic oxytocin to attenuate alcohol intake. Male and female Sprague-Dawley rats were assessed for baseline anxiety-like behavior using acoustic startle and the elevated plus maze (EPM). Rats were then given 2-bottle choice access to oxycodone and/or water for 6-hr/day for 7 days, followed by 2-bottle choice access to alcohol (20% v/v) and/or water for five 24-hr sessions across 10 days. Next, monosubstance (oxycodone- or alcohol-alone) rats continued to have access to only one substance/day while PSU rats had access to oxycodone and water for 3-hr, followed by alcohol and water for 6-hr. After 12 days, rats were tested in the EPM 20 hours after alcohol access to examine withdrawal-related anxiety. Next, oxytocin (0, 0.3 or 1.0 mg/kg IP) was administered following the oxycodone/water session, 30 minutes prior to alcohol access. Rats received intragastric oxycodone (2 mg/kg) or water followed by intragastric alcohol (2 g/kg) and blood was collected to determine blood alcohol levels. Elevated baseline anxiety-like behavior was accompanied by reduced alcohol intake. Consumption of oxycodone did not alter alcohol intake but resulted in less anxiety-like behavior during withdrawal and prevented oxytocin from attenuating alcohol intake. Oxytocin (1 mg/kg) reduced alcohol intake in the alcohol-only condition, an effect that persisted for days after a single oxytocin administration. Rats that received oxycodone prior to non-contingent alcohol displayed higher blood alcohol levels than those that did not. These results support the necessity for the testing of medications for substance use in rodent models of PSU. •Sequential oxycodone-alcohol intake does not influence intake of either drug.•Systemic oxytocin reduces alcohol intake in rats.•A history of oxycodone consumption prevents oxytocin from reducing alcohol intake.•Sequential consumption of oxycodone and alcohol results in less anxiety-like behavior.</description><identifier>ISSN: 0741-8329</identifier><identifier>ISSN: 1873-6823</identifier><identifier>EISSN: 1873-6823</identifier><identifier>DOI: 10.1016/j.alcohol.2024.10.002</identifier><identifier>PMID: 39447851</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>comorbidity ; oral self-administration ; polydrug</subject><ispartof>Alcohol (Fayetteville, N.Y.), 2024-10</ispartof><rights>2024 Elsevier Inc.</rights><rights>Copyright © 2024 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1581-f06e1357cee3af7fdaa71545bb673697a9c14db6cf801df08959500b0faa6e893</cites><orcidid>0000-0003-1834-7021 ; 0000-0003-2524-6739 ; 0009-0002-4329-8583 ; 0009-0004-9119-7212 ; 0009-0007-4729-3014</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.alcohol.2024.10.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27926,27927,45997</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39447851$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wilkinson, C.S.</creatorcontrib><creatorcontrib>Modrak, C.G.</creatorcontrib><creatorcontrib>Thompson, T.D.</creatorcontrib><creatorcontrib>Conrad, R.C.</creatorcontrib><creatorcontrib>Leon, I.</creatorcontrib><creatorcontrib>Knackstedt, L.A.</creatorcontrib><title>Consumption of oxycodone prevents oxytocin from attenuating alcohol intake in rats</title><title>Alcohol (Fayetteville, N.Y.)</title><addtitle>Alcohol</addtitle><description>Alcohol and opioid polysubstance use (PSU) is common and often accompanied by higher trait anxiety. Oxytocin decreases anxiety, alcohol- and opioid-seeking and -taking but has not been assessed in the context of PSU. Here we developed a rat model of sequential oxycodone and alcohol PSU to examine the relationship between anxiety, alcohol and oxycodone intake, and the efficacy of systemic oxytocin to attenuate alcohol intake. Male and female Sprague-Dawley rats were assessed for baseline anxiety-like behavior using acoustic startle and the elevated plus maze (EPM). Rats were then given 2-bottle choice access to oxycodone and/or water for 6-hr/day for 7 days, followed by 2-bottle choice access to alcohol (20% v/v) and/or water for five 24-hr sessions across 10 days. Next, monosubstance (oxycodone- or alcohol-alone) rats continued to have access to only one substance/day while PSU rats had access to oxycodone and water for 3-hr, followed by alcohol and water for 6-hr. After 12 days, rats were tested in the EPM 20 hours after alcohol access to examine withdrawal-related anxiety. Next, oxytocin (0, 0.3 or 1.0 mg/kg IP) was administered following the oxycodone/water session, 30 minutes prior to alcohol access. Rats received intragastric oxycodone (2 mg/kg) or water followed by intragastric alcohol (2 g/kg) and blood was collected to determine blood alcohol levels. Elevated baseline anxiety-like behavior was accompanied by reduced alcohol intake. Consumption of oxycodone did not alter alcohol intake but resulted in less anxiety-like behavior during withdrawal and prevented oxytocin from attenuating alcohol intake. Oxytocin (1 mg/kg) reduced alcohol intake in the alcohol-only condition, an effect that persisted for days after a single oxytocin administration. Rats that received oxycodone prior to non-contingent alcohol displayed higher blood alcohol levels than those that did not. These results support the necessity for the testing of medications for substance use in rodent models of PSU. •Sequential oxycodone-alcohol intake does not influence intake of either drug.•Systemic oxytocin reduces alcohol intake in rats.•A history of oxycodone consumption prevents oxytocin from reducing alcohol intake.•Sequential consumption of oxycodone and alcohol results in less anxiety-like behavior.</description><subject>comorbidity</subject><subject>oral self-administration</subject><subject>polydrug</subject><issn>0741-8329</issn><issn>1873-6823</issn><issn>1873-6823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFUMFqGzEUFKEhdtx-Qssee1n3abVarU6lmKQNBAIhOQut9imRuyu5ktbEf581dnvtaWCYefNmCPlMYU2BNt-2az2Y8BqGdQVVPXNrgOqCLGkrWNm0FftAliBqWraskgtyndIWAIQQ8oosmKxr0XK6JI-b4NM07rILvgi2CG8HE_rgsdhF3KPP6UjlYJwvbAxjoXNGP-ns_Etx_qBwPuvfOEMRdU4fyaXVQ8JPZ1yR59ubp82v8v7h593mx31pKG9paaFByrgwiExbYXutBeU177pGsEYKLQ2t-64xtgXaW2gllxygA6t1g61kK_L1dHcXw58JU1ajSwaHQXsMU1KMVsBlwxidpfwkNTGkFNGqXXSjjgdFQR3nVFt1LqOOcx7pec7Z9-UcMXUj9v9cf_ebBd9PApyL7h1GlYxDb7B3EU1WfXD_iXgH_WmKVg</recordid><startdate>20241022</startdate><enddate>20241022</enddate><creator>Wilkinson, C.S.</creator><creator>Modrak, C.G.</creator><creator>Thompson, T.D.</creator><creator>Conrad, R.C.</creator><creator>Leon, I.</creator><creator>Knackstedt, L.A.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1834-7021</orcidid><orcidid>https://orcid.org/0000-0003-2524-6739</orcidid><orcidid>https://orcid.org/0009-0002-4329-8583</orcidid><orcidid>https://orcid.org/0009-0004-9119-7212</orcidid><orcidid>https://orcid.org/0009-0007-4729-3014</orcidid></search><sort><creationdate>20241022</creationdate><title>Consumption of oxycodone prevents oxytocin from attenuating alcohol intake in rats</title><author>Wilkinson, C.S. ; Modrak, C.G. ; Thompson, T.D. ; Conrad, R.C. ; Leon, I. ; Knackstedt, L.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1581-f06e1357cee3af7fdaa71545bb673697a9c14db6cf801df08959500b0faa6e893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>comorbidity</topic><topic>oral self-administration</topic><topic>polydrug</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wilkinson, C.S.</creatorcontrib><creatorcontrib>Modrak, C.G.</creatorcontrib><creatorcontrib>Thompson, T.D.</creatorcontrib><creatorcontrib>Conrad, R.C.</creatorcontrib><creatorcontrib>Leon, I.</creatorcontrib><creatorcontrib>Knackstedt, L.A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Alcohol (Fayetteville, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wilkinson, C.S.</au><au>Modrak, C.G.</au><au>Thompson, T.D.</au><au>Conrad, R.C.</au><au>Leon, I.</au><au>Knackstedt, L.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Consumption of oxycodone prevents oxytocin from attenuating alcohol intake in rats</atitle><jtitle>Alcohol (Fayetteville, N.Y.)</jtitle><addtitle>Alcohol</addtitle><date>2024-10-22</date><risdate>2024</risdate><issn>0741-8329</issn><issn>1873-6823</issn><eissn>1873-6823</eissn><abstract>Alcohol and opioid polysubstance use (PSU) is common and often accompanied by higher trait anxiety. Oxytocin decreases anxiety, alcohol- and opioid-seeking and -taking but has not been assessed in the context of PSU. Here we developed a rat model of sequential oxycodone and alcohol PSU to examine the relationship between anxiety, alcohol and oxycodone intake, and the efficacy of systemic oxytocin to attenuate alcohol intake. Male and female Sprague-Dawley rats were assessed for baseline anxiety-like behavior using acoustic startle and the elevated plus maze (EPM). Rats were then given 2-bottle choice access to oxycodone and/or water for 6-hr/day for 7 days, followed by 2-bottle choice access to alcohol (20% v/v) and/or water for five 24-hr sessions across 10 days. Next, monosubstance (oxycodone- or alcohol-alone) rats continued to have access to only one substance/day while PSU rats had access to oxycodone and water for 3-hr, followed by alcohol and water for 6-hr. After 12 days, rats were tested in the EPM 20 hours after alcohol access to examine withdrawal-related anxiety. Next, oxytocin (0, 0.3 or 1.0 mg/kg IP) was administered following the oxycodone/water session, 30 minutes prior to alcohol access. Rats received intragastric oxycodone (2 mg/kg) or water followed by intragastric alcohol (2 g/kg) and blood was collected to determine blood alcohol levels. Elevated baseline anxiety-like behavior was accompanied by reduced alcohol intake. Consumption of oxycodone did not alter alcohol intake but resulted in less anxiety-like behavior during withdrawal and prevented oxytocin from attenuating alcohol intake. Oxytocin (1 mg/kg) reduced alcohol intake in the alcohol-only condition, an effect that persisted for days after a single oxytocin administration. Rats that received oxycodone prior to non-contingent alcohol displayed higher blood alcohol levels than those that did not. These results support the necessity for the testing of medications for substance use in rodent models of PSU. •Sequential oxycodone-alcohol intake does not influence intake of either drug.•Systemic oxytocin reduces alcohol intake in rats.•A history of oxycodone consumption prevents oxytocin from reducing alcohol intake.•Sequential consumption of oxycodone and alcohol results in less anxiety-like behavior.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39447851</pmid><doi>10.1016/j.alcohol.2024.10.002</doi><orcidid>https://orcid.org/0000-0003-1834-7021</orcidid><orcidid>https://orcid.org/0000-0003-2524-6739</orcidid><orcidid>https://orcid.org/0009-0002-4329-8583</orcidid><orcidid>https://orcid.org/0009-0004-9119-7212</orcidid><orcidid>https://orcid.org/0009-0007-4729-3014</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0741-8329
ispartof Alcohol (Fayetteville, N.Y.), 2024-10
issn 0741-8329
1873-6823
1873-6823
language eng
recordid cdi_proquest_miscellaneous_3120596331
source Access via ScienceDirect (Elsevier)
subjects comorbidity
oral self-administration
polydrug
title Consumption of oxycodone prevents oxytocin from attenuating alcohol intake in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T16%3A06%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Consumption%20of%20oxycodone%20prevents%20oxytocin%20from%20attenuating%20alcohol%20intake%20in%20rats&rft.jtitle=Alcohol%20(Fayetteville,%20N.Y.)&rft.au=Wilkinson,%20C.S.&rft.date=2024-10-22&rft.issn=0741-8329&rft.eissn=1873-6823&rft_id=info:doi/10.1016/j.alcohol.2024.10.002&rft_dat=%3Cproquest_cross%3E3120596331%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3120596331&rft_id=info:pmid/39447851&rft_els_id=S0741832924001289&rfr_iscdi=true